Hydroxychloroquine – New Evidence for Better Pregnancy Outcomes in APS
Aya Berman, Family medicine resident at Clalit Health Services, shared a post on LinkedIn:
“Thrilled to share our new study: ‘Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis” is now published in RMD Open.
This study represents a meaningful step in understanding the role of hydroxychloroquine in improving obstetric outcomes for patients with antiphospholipid syndrome.
The findings were first presented by Dr. Orly Efros at the International Society on Thrombosis and Haemostasis (ISTH) Annual Congress in Bangkok, and I am delighted that the full manuscript is now available here.
Grateful to my colleagues and collaborators for their dedication and contributions that made this work possible!
Orly Efros, Gili Kenet, Aharon lubetsky, Nancy Agmon-Levin, Shelly Soffer, MD, assaf barg, Sarina Levy mendelovich, omri cohen, Liat Waldman Radinsky, Shadan Lalezari, Eyal Klang”
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch